复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识(2016年)

2016-10-01 中华中医药学会皮肤科专业委员会 中国中西医结合皮肤性病学杂志.2016,15(5):290-291.

复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中已经得到广泛应用,为了更好地了解复方黄柏液涂剂的临床应用情况,以中华中医药学会皮肤性病学专业委员会部分专家为基础,邀请部分知名中医专家和儿科皮肤专家参加制定本共识

中文标题:

复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识(2016年)

发布日期:

2016-10-01

简要介绍:

内容介绍:
复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中已经得到广泛应用,为了更好地了解复方黄柏液涂剂的临床应用情况,以中华中医药学会皮肤性病学专业委员会部分专家为基础,邀请部分知名中医专家和儿科皮肤专家参加制定本共识,旨在帮助皮肤科医生与儿科医生了解外用复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中的使用现状,发现问题,总结经验,以便更好地发挥复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中的作用,提高儿童用药的安全。参加制定本共识的专家包括(排名不分先后):杨志波、段逸群、张晓杰、周小勇、张理涛、杨素清、白彦萍、谭城、王军文、宋坪、刁庆春、邓常清等。 拓展指南:湿疹相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识(2016年))] GetToolGuiderByIdResponse(projectId=1, id=d96101c00132933a, title=复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识(2016年), enTitle=, guiderFrom=中国中西医结合皮肤性病学杂志.2016,15(5):290-291., authorId=null, author=, summary=复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中已经得到广泛应用,为了更好地了解复方黄柏液涂剂的临床应用情况,以中华中医药学会皮肤性病学专业委员会部分专家为基础,邀请部分知名中医专家和儿科皮肤专家参加制定本共识, cover=, journalId=null, articlesId=null, associationId=874, associationName=中华中医药学会皮肤科专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Oct 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=内容介绍:<br> 复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中已经得到广泛应用,为了更好地了解复方黄柏液涂剂的临床应用情况,以中华中医药学会皮肤性病学专业委员会部分专家为基础,邀请部分知名中医专家和儿科皮肤专家参加制定本共识,旨在帮助皮肤科医生与儿科医生了解外用复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中的使用现状,发现问题,总结经验,以便更好地发挥复方黄柏液涂剂在儿童湿疹、脓疱疮、特应性皮炎治疗中的作用,提高儿童用药的安全。参加制定本共识的专家包括(排名不分先后):杨志波、段逸群、张晓杰、周小勇、张理涛、杨素清、白彦萍、谭城、王军文、宋坪、刁庆春、邓常清等。 拓展指南:<strong>与<font color="red">湿疹</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=0bd671c0012e6510" title="2015 小儿湿疹局部用中药新药临床试验设计与评价技术指南" target="_blank">2015 小儿湿疹局部用中药新药临床试验设计与评价技术指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b4ed51c0011ea5d8" title="中西医结合系统药物治疗湿疹皮炎类皮肤病专家共识(2015版)" target="_blank">中西医结合系统药物治疗湿疹皮炎类皮肤病专家共识(2015版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=347411c00113e77f" title="2015 ESCD指南:手部湿疹的诊断,预防和治疗(简要版)" target="_blank">2015 ESCD指南:手部湿疹的诊断,预防和治疗(简要版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3566b1c0010852ac" title="外用中成药治疗湿疹皮炎的专家共识(2014)" target="_blank">外用中成药治疗湿疹皮炎的专家共识(2014)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9f9e01c0009ae878" title="2012 外用中成药治疗湿疹皮炎的专家共识" target="_blank">2012 外用中成药治疗湿疹皮炎的专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%B9%BF%E7%96%B9" target="_blank">有关湿疹更多指南</a></ul>, tagList=[TagDto(tagId=9960, tagName=湿疹)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5960, appHits=414, showAppHits=0, pcHits=3822, showPcHits=2783, likes=146, shares=25, comments=5, approvalStatus=1, publishedTime=Wed Nov 16 16:35:03 CST 2016, publishedTimeString=2016-10-01, pcVisible=1, appVisible=1, editorId=5295955, editor=yingzheng.gu, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yingzheng.gu, createdTime=Wed Nov 16 16:35:03 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 18:51:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识(2016年))])
复方黄柏液涂剂治疗儿童湿疹、脓疱疮、特应性皮炎专家共识(2016年)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1209145, encodeId=d60f120914552, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:44:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156912, encodeId=81b3156912e0, content=在哪可以看到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=111c1977572, createdName=1e176133m09(暂无匿称), createdTime=Sat Nov 19 21:35:53 CST 2016, time=2016-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156663, encodeId=04d815666311, content=学习并分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Nov 18 20:18:15 CST 2016, time=2016-11-18, status=1, ipAttribution=)]
    2022-04-07 ms4000000065127311

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1209145, encodeId=d60f120914552, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:44:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156912, encodeId=81b3156912e0, content=在哪可以看到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=111c1977572, createdName=1e176133m09(暂无匿称), createdTime=Sat Nov 19 21:35:53 CST 2016, time=2016-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156663, encodeId=04d815666311, content=学习并分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Nov 18 20:18:15 CST 2016, time=2016-11-18, status=1, ipAttribution=)]
    2016-11-19 1e176133m09(暂无匿称)

    在哪可以看到

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1209145, encodeId=d60f120914552, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e06a6525385, createdName=ms4000000065127311, createdTime=Thu Apr 07 07:44:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156912, encodeId=81b3156912e0, content=在哪可以看到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=111c1977572, createdName=1e176133m09(暂无匿称), createdTime=Sat Nov 19 21:35:53 CST 2016, time=2016-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156663, encodeId=04d815666311, content=学习并分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Nov 18 20:18:15 CST 2016, time=2016-11-18, status=1, ipAttribution=)]
    2016-11-18 大爰

    学习并分享

    0